ParkinsonCanadaV1, France, Analysis, indexHead, KwdEn.i

Index : Keywords

Liste des classifications (clusters par fréquence et par distance de cosinus):

Les termes de plus forte occurence

85	Parkinson disease
53	Humans
51	Nervous system diseases
36	Human
27	Male
27	Female
26	Parkinson's disease
22	Treatment
18	Middle Aged
17	Parkinson Disease (therapy)
17	Levodopa
17	Deep brain stimulation
17	Animals
16	Aged
14	Parkinson Disease (physiopathology)
13	Dyskinesia
12	Subthalamic nucleus
11	deep brain stimulation
11	Adult
10	Dopamine agonist
10	Animal
8	Treatment Outcome
8	Dopamine
8	Deep Brain Stimulation (methods)
7	Severity of Illness Index
7	Parkinson Disease (drug therapy)
7	Parkinson Disease (diagnosis)
7	Diagnosis
7	Chemotherapy
6	Subthalamic Nucleus (physiology)
6	Ropinirole
6	Review
6	Neuropsychological Tests
6	Clinical management
6	Basal ganglion
6	Antiparkinson agent
5	levodopa
5	dyskinesia
5	Parkinson Disease (complications)
5	Neuroprotective agent
5	Monkey
5	Mice
5	Dystonia
5	Double blind study
5	Depression
5	Dementia
5	Deep Brain Stimulation
5	Comparative study
5	Cognition
5	Brain (vertebrata)
5	Analysis of Variance
5	Alzheimer disease
5	Agonist
4	subthalamic nucleus
4	dopamine agonists
4	Tremor
4	Surgery
4	Rat
4	Posture
4	Plasticity
4	Phenotype
4	Parkinsonism
4	Parkinson Disease (psychology)
4	Mouse
4	Medicine
4	Magnetic Resonance Imaging
4	Long term
4	In vitro
4	Executive function
4	Encephalon
4	Dopaminergic neuron
4	D2 Dopamine receptor
4	Brain (physiopathology)
3	treatment
3	rating scales
3	dopamine
3	clinimetrics
3	Toxicity
3	Time Factors
3	Technique
3	Serotonin
3	Selectivity
3	Prognosis
3	Primates
3	Placebo
3	Partial agonist
3	Parkinson Disease (pathology)
3	Parkinson Disease (genetics)
3	Neurotoxin
3	Mutation (genetics)
3	Multicenter study
3	Motor Cortex (physiology)
3	Mitochondria
3	Mice, Inbred C57BL
3	MPTP
3	Inhibition (Psychology)
3	Follow-Up Studies
3	Facial expression
3	Exploration
3	Evaluation scale
3	Emission tomography
3	Electromyography
3	Double-Blind Method
3	Dopamine (metabolism)
3	Disease Models, Animal
3	Complication
3	Apoptosis
3	Antiparkinson Agents (therapeutic use)
3	Animal model
3	Anatomy
3	Aminoacid
3	Aged, 80 and over
2	thalamotomy
2	ropinirole
2	quality of life
2	photodynamic therapy
2	partial dopamine agonist
2	motor complications
2	methods: statistical
2	immunocytochemistry
2	glutamate
2	evidence‐based medicine
2	dystonia
2	dopamine transporter
2	diagnostic criteria
2	diagnosis
2	Young Adult
2	Validation
2	Transferrin
2	Tookad
2	Subthalamic Nucleus (physiopathology)
2	Subcortex
2	Structure activity relation
2	Stress
2	Societies, Scientific (standards)
2	Sleep disorder
2	Safety
2	Risk factor
2	Revision
2	Restless legs syndrome
2	Reference Standards
2	Reaction Time (physiology)
2	Rasagiline
2	Randomization
2	Radiodiagnosis
2	Quality of Life
2	Quality of Life (psychology)
2	Psychotropic
2	Psychosis
2	Psychiatric Status Rating Scales
2	Prospective Studies
2	Postural fitting
2	Postoperative Complications
2	Positron
2	Pituitary adenylate cyclase activating peptide
2	Pedunculopontine Tegmental Nucleus (physiopathology)
2	Pathophysiology
2	Pathogenesis
2	Parkinson’s disease
2	Parkinson Disease (surgery)
2	Parkinson Disease (mortality)
2	Parkinson Disease (metabolism)
2	Parkinson Disease (diagnostic imaging)
2	Pardoprunox
2	Pallidum
2	Nuclear magnetic resonance imaging
2	Nootropic agent
2	Neuronal Plasticity (physiology)
2	Neuron
2	Nerve Net (physiopathology)
2	Myelodysplastic syndrome
2	Mutation
2	Multicatalytic endopeptidase complex
2	Motor system disorder
2	Motor control
2	Motor Cortex (physiopathology)
2	Motor Activity
2	Morphology
2	Mood Disorders (etiology)
2	Modification
2	Midbrain
2	Mice, Knockout
2	Medical imagery
2	Mechanism of action
2	Low dose
2	Levodopa (therapeutic use)
2	Levodopa (adverse effects)
2	Levetiracetam
2	Isthmo-optic nucleus
2	Iron
2	Ions
2	In vivo
2	Immunohistochemistry
2	Idiopathic
2	Hyperkinesia
2	Heme
2	Guidelines as Topic
2	Gene therapy
2	Gait (physiology)
2	Face
2	Evoked Potentials, Motor (physiology)
2	Evidence-based medicine
2	Evaluation
2	Emotion emotionality
2	Electroencephalography
2	Elderly
2	Dopaminergic pathway
2	Dopamine (physiology)
2	Dopa
2	Development
2	Depression (etiology)
2	Depletion
2	Degeneration
2	Deep Brain Stimulation (instrumentation)
2	D3 Dopamine receptor
2	Cross-Over Studies
2	Corpus striatum
2	Conserved Sequence
2	Computational Biology
2	Cognition Disorders (etiology)
2	Cognition Disorders (diagnosis)
2	Clinical trial
2	Chronic
2	ChAT
2	Cerebral disorder
2	Centrifugal visual system
2	Central nervous system
2	Cartography
2	Carrier Proteins (genetics)
2	Brain (pathology)
2	Brain (metabolism)
2	Behavior
2	Atlas
2	Apathy
2	Apathy (physiology)
2	Antiparkinson Agents (adverse effects)
2	Amine oxidase (flavin-containing)
2	Adolescent
1	α1-Adrenergic receptor
1	wehrlite
1	wearing off
1	warping
1	volar pads
1	ventricular tachycardia
1	ventricular fibrillation
1	vascular effects
1	variability
1	validity
1	urinary disorder
1	trout
1	tricyclic antidepressants
1	translational
1	transcranial magnetic stimulation
1	trade‐offs
1	tobacco dependence
1	thalamic deep brain stimulation
1	term values
1	temperature
1	tauopathies
1	task force
1	systems biology
1	synaptic frequency
1	surgical planning
1	surgery
1	supraspinatus tendon
1	suggested immobilization test
1	subthalamic
1	submillimetre: galaxies
1	stroke
1	striatum
1	streams
1	steroid
1	stars: neutron
1	spinal muscular atrophy
1	spinal cord injury
1	speech therapy
1	size‐at‐age
1	selective serotonin reuptake inhibitors (SSRIs)
1	selective estrogen receptor modulator
1	scoring
1	schizophrenia
1	scanning probe microscopy
1	salmon
1	safety
1	retinopetal neurons
1	restless legs syndrome
1	resource allocation
1	resource acquisition
1	reproductive investment
1	reliability
1	rehabilitation
1	refixation
1	rat liver
1	rasagiline
1	randomized controlled trial
1	randomized controlled clinical trial
1	publication guidelines
1	proteoglycans
1	protein–protein interactions
1	protein production
1	protease inhibitors
1	prostate
1	prostate cancer
1	progressive supranuclear palsy
1	programming
1	productivity
1	principal component analysis
1	prevention
1	predictive factors
1	polycycles
1	physical therapy
1	photorespiration
1	photoelectron spectroscopy
1	phenobarbital
1	pharmacokinetics
1	periodic limb movements
1	peridotite
1	perampanel
1	pathological gambling
1	parkinsonism
1	pardoprunox
1	pardoprunox (SLV308)
1	parameter
1	pallidotomy
1	palaeoceanography
1	pace‐of‐life syndrome hypothesis
1	p120RasGAP
1	omega‐3 fatty‐acids
1	occupational therapy
1	n‐of‐1 trial
1	nuclear receptors
1	nitrogen heterocycles
1	nitric oxide
1	nicotine
1	nicotine binding
1	niche
1	neurotrophins
1	neurotoxicity
1	neurotensin
1	neurosurgery
1	neuroprotection
1	neuropeptides
1	neurogenic bladder
1	neurofilaments
1	neurofibromin
1	neurofibroma
1	naftazone
1	multiple system atrophy
1	movement disorders
1	movement disorder
1	motor thalamus
1	motor fluctuations
1	monotherapy
1	monoamine oxidase inhibitors
1	monoamine oxidase B inhibitors
1	microtubule‐associated protein tau
1	microtubules
1	microenvironment
1	microdialysis
1	metabolism
1	melt–rock reaction
1	maturation
1	mantle xenolith
1	malformation
1	maintenance
1	macaque
1	mRNA
1	long‐term evolution
1	long-term effects
1	limbic system
1	life‐history trade‐offs
1	laser-induced amplified spontaneous emission
1	in vivo electrophysiology
1	internal conductance
1	intergalactic medium
1	infrared: galaxies
1	indications
1	in situ hybridization
1	hydrogen bonds
1	human disease
1	high-resolution Fourier transform spectrometry
1	hereditary hemorrhagic telangiectasia
1	hereditary benign telangiectasia
1	heart failure
1	guidelines
1	growth
1	glycosaminoglycans
1	globus pallidus
1	globus pallidus pars interna
1	globus pallidus internus
1	gene‐based
1	gamma‐rays: bursts
1	gamma-Aminobutyric Acid (metabolism)
1	galaxies: statistics
1	galaxies: individual: NGC 1275
1	galaxies: clusters: general
1	functional modules
1	frontotemporal dementia with parkinsonism linked to chromosome 17
1	fishing‐induced evolution
1	fetal pads
1	feeding latency
1	ezrin
1	extracellular matrix
1	exploration
1	exercise
1	executive functions
1	endopeptidase
1	emotion processing
1	electron microscopy radioautography
1	efficacy
1	drug
1	drug efflux transporters
1	dronedarone
1	dopamine agonist
1	disease modification
1	depression
1	density functional calculations
1	dementia
1	delayed start design
1	deep brain stimulation (DBS)
1	database schema
1	c‐Src
1	cytochrome P450
1	crocodilian
1	corticobasal degeneration
1	conversion
1	contraindications
1	compensation point
1	cognition
1	clozapine
1	clonality
1	chorea
1	chondrogenesis
1	chirality
1	cell–cell contacts
1	cell scattering
1	celivarone
1	catheter ablation
1	catechol‐O‐methyl transferase inhibitors
1	catecholmethyltransferase inhibitors
1	carcinomas
1	carbon and oxygen stable isotopes
1	capillary
1	cannabinoid
1	cadherins
1	blood–brain barrier
1	benign
1	behaviour
1	atrial flutter
1	atrial fibrillation
1	atlas customization
1	association
1	arteriovenous
1	arteriovenous fistula
1	antipeptide antibodies
1	anticholinergics
1	amiodarone
1	amantadine
1	alternative splicing
1	alpha-Synuclein (metabolism)
1	alpha-Synuclein (analysis)
1	acupuncture
1	[3H]SR142948A
1	Young adult
1	X‐rays: galaxies
1	Working memory
1	Woman
1	Wavelet Analysis
1	WAIS-R, Wechsler adult intelligence scale, revised
1	Visual cortex
1	Virulence
1	Vesicular Glutamate Transport Protein 2 (metabolism)
1	Variability
1	Validity
1	VR1 vanilloid receptor
1	Urea (therapeutic use)
1	Urea (analogs & derivatives)
1	Uptake
1	Unified Parkinson's Disease Rating Scale
1	Ubiquitination
1	Ubiquitin
1	Ubiquitin-Protein Ligases (metabolism)
1	Ubiquitin-Protein Ligases (genetics)
1	UPDRS
1	UPDRS, unified Parkinson’s disease rating scale
1	UPDRS = Unified Parkinson's Disease Rating Scale
1	UML data model
1	Tyrosine
1	Tyrosine 3-monooxygenase
1	Tritium
1	Trihexyphenidyl
1	Trihexyphenidyl (adverse effects)
1	Treatment efficiency
1	Transferases
1	Transfection
1	Transcription Factors (metabolism)
1	Transcription Factors (genetics)
1	Transcranial magnetic stimulation
1	Transcranial Magnetic Stimulation
1	Toxoplasma (pathogenicity)

Manipulations en shell (Unix/Dilib)

HfdCat /applis/lorexplor/Wicri/Amerique/Canada/explor/ParkinsonCanada.storage/ParkisonCanadaV1/Data/France/Analysis/KwdEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration) - Analysis (France) Index « Mots-clés originaux en anglais » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration) - Analysis (France)Index « Mots-clés originaux en anglais » - tête de navigation

Index : Keywords

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

La maladie de Parkinson au Canada (serveur d'exploration) - Analysis (France)

Index « Mots-clés originaux en anglais » - tête de navigation